¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"erythema dose"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • erythema multiforme bullosum
    ¹°Áý´ÙÇüÈ«¹Ý
  • erythema multiforme exudativum
    »ïÃâ´ÙÇüÈ«¹Ý
  • erythema nodosum
    °áÀýÈ«¹Ý
  • erythema nodosum leprosum
    ³ªº´°áÀýÈ«¹Ý
  • erythema nodosum migrans
    À̵¿°áÀýÈ«¹Ý
  • familial annulare erythema
    °¡Á·¼ºÀ±»óÈ«¹Ý, °¡Á·¼º°í¸®È«¹Ý
  • gyrate erythema
    À̶ûÈ«¹Ý
  • morbilliform erythema
    È«¿ª¸ð¾çÈ«¹Ý
  • necrolytic migratory erythema
    ±«»ç¿ëÇØÀ̵¿È«¹Ý
  • solar erythema
    Àϱ¤È«¹Ý
  • acceptable daily dose
    ÀÏÀÏÇã¿ë·®
  • average dose
    1. Æò±Õ¿ë·® 2. Æò±Õ¼±·®
  • air dose
    °ø±â¼±·®
  • absorbed dose
    Èí¼ö¼±·®
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dose-response relationship
    ¿ë·®¹ÝÀÀ°ü°è
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • erythema infectiosum
    °¨¿°È«¹Ý
  • erythema marginatum
    ¿¬º¯È«¹Ý, °æ°èÈ«¹Ý
  • erythema medicamentosum
    ¾à¹°È«¹Ý
  • erythema migrans
    À̵¿È«¹Ý
  • erythema multiforme
    ´ÙÇüÈ«¹Ý
  • erythema multiforme bullosum
    ´ÙÇü¹°ÁýÈ«¹Ý
  • erythema multiforme exudativum
    ´ÙÇü»ïÃâÈ«¹Ý
  • erythema nodosum
    °áÀýÈ«¹Ý
  • erythema nodosum leprosum
    ³ªº´°áÀýÈ«¹Ý
  • erythema nodosum migrans
    À̵¿°áÀýÈ«¹Ý
  • erythema papulatum
    ±¸ÁøÈ«¹Ý
  • erythema perstans
    Áö¼ÓÈ«¹Ý
  • erythema vacciniforme
    Á¾µÎÁõ¸ð¾çÈ«¹Ý
  • familial annulare erythema
    °¡Á·À±»óÈ«¹Ý, °¡Á·°í¸®È«¹Ý
  • guttate erythema
    ¹°¹æ¿ïÈ«¹Ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • LD= lethal dose
    Ä¡»ç·®.
  • MED => minimum effective dose
    ÃÖ¼ÒÈ«¹Ý·®
  • MED=> minimum effective dose
    ÃÖ¼ÒÀ¯È¿·®.
  • MED=£¾minimum effective dose
    ÃÖ¼ÒÀ¯È¿·®.
  • MTD=> maximum toderance dose
    ÃÖ´ë³»¿ë·®.
  • MTD=£¾maximum tolerance dose
    ÃÖ´ë³»¿ë·®.
  • MTD=ÊÝmaximum toderance dose
    ÃÖ´ë³»¿ë·®.
  • STD= standard test dose
    Ç¥ÁؽÃÇè·®.
  • absorbed dose
    Èí¼ö·®.¹æ»ç¼±Èí¼ö¼±·®(ýåâ¥àÊåÖ).
  • absorbed dose
    Èí¼ö¼±·®
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • absorbed dose rate
    Èí¼ö¼±·®À²
  • acceptable daily dose : ADD
    ÀÏÀÏÇã¿ë·®(ìéìíúÉé»Õá).
  • acceptable dose
    ¿ëÀμ±·®, ¼ö¿ë¼±·®, Çã¿ë¼±·®
  • adult dosage =a. dose
    ¼ºÀη®, ¼ºÀο뷮.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cold erythema
    ÇÑ·©È«¹Ý
  • congenital telangiectatic erythema
    ¼±Ãµ¼º(à»ô¸àõ) ¸ð¼¼Ç÷°üÈ®À强 È«¹Ý(Ù½á¬úìηüªíåàõ ûõÚè)
  • diaper erythema
    ±âÀú±ÍÈ«¹Ý(¡­ûõÚè).
  • erythema
    È«¹Ý(ûõÚè)
  • erythema
    È«¹Ý(ûõÚè)
  • erythema ab igne<³ª>
    ¿­¼ºÈ«¹Ý
  • erythema allergicum neonatorum
    ¾Ë·¹¸£±â¼º ½Å»ý¾Æ È«¹Ý
  • erythema annulare angioneuroticum<³ª>
    Ç÷°ü½Å°æ¼º À±»óÈ«¹Ý
  • erythema annulare centrifugum<³ª>
    Á߽ɿø½É¼º À±»óÈ«¹Ý
  • erythema annulare rheumaticum<³ª>
    ·ù¸¶Æ¼½º¼º À±»óÈ«¹Ý
  • erythema annulare<³ª>
    À±»ó(ëÌßÒ)È«¹Ý
  • erythema chronicum migrans
    À¯ÁÖ¼º ¸¸¼ºÈ«¹Ý(ë´ñËàõØ·àõûõÚì)
  • erythema chronicum migrans
    À¯ÁÖ¼º ¸¸¼ºÈ«¹Ý(ë´ñËàõ Ø·àõ¡­)
  • erythema chronicum migrans<³ª>
    À¯ÁÖ¼º ¸¸¼º(ë´ñËàõØ·àõ) È«¹Ý
  • erythema circinatum<³ª>
    ȯ»óÈ«¹Ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • median tissue culture dose
    Á¤ÁßÁ¶Á÷¹è¾ç·®(ïáñéðÚòÄÛÆå×Õá)
  • median toxic dose
    Á¤Áß µ¶¼º·®(ïáñéÔ¸àõÕá)
  • minimum hemagglutinating dose
    ÃÖ¼ÒÇ÷±¸ÀÀÁý·®(õÌá³úìϹëêó¢Õá)
  • minimum hemolytic dose
    ÃÖ¼Ò¿ëÇ÷·®(õÌá³éÁúìÕá)
  • minbimum lethal dose
    ÃÖ¼ÒÄ¡»ç·®(õÌá³öÈÞÝÕá)
  • permissible dose
    Çã¿ë·®(úÉé»Õá)
  • priming dose
    ÀÏÂ÷󸮿뷮(ìéó­ô¥×âéÄÕá)
  • radiation absorbed dose
    ¹æ»ç¼± Èí¼ö·®(Û¯ÞÒàÊýåâ¥Õá)
  • radiation dose
    ¹æ»ç¼±·®(Û¯ÞÒàÊÕá)
  • threshold dose
    ¹®ÅÎ ¼±·®(àÊÕá)
  • tissue culture infectious dose
    Á¶Á÷¹è¾ç °¨¿°·® (ðÚòÄÛÆå×ÊïæøÕá)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • midbreast dose
    À¯¹æÁß¾ÓÁ¶»ç¼±·®
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • permissible internal dose
    ³»ºÎÇã¿ë¼±·®
  • radiation absorbed dose
    ¶óµå, ¹æ»ç¼±Èí¼ö¼±·®
  • relative dose
    ºñ±³Á¶»ç·®, »ó´ëÁ¶»ç·®
  • single dose
    ÀÏȸ·®
  • skin dose
    ÇǺμ±·®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EM early memory; ejection murmur; electromagnetic; electron micrograph; electron microscopy, electron m...
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
LD labor and delivery; laboratory data; labyrinthine defect; lactate dehydrogenase; laser Doppler; lear...
MD Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major...
MID maximum inhibiting dilution; mesioincisodistal; midinfarct dementia; minimum infective dose; minimum...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
E.c.m. Erythema chronicum migrans
E.e.d. Erythema elevatum diutinum
EM Erythema migrams
BMD Benchmark dose
BED Biologically Effective Dose
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • erythema wheal reaction
    È«¹Ý ±¸Áø ¹ÝÀÀ
    ¾Ë·¹¸£±â¿øÀÇ °¨ÀÛ »óŸ¦ °Ë»öÇÒ ¸ñÀûÀ¸·Î ¾Ë·¹¸£±â¿ø ÃßÃâ¹°À» ÇǺΠǥ¸é¿¡ ÇÑ ¹æ¿ï ¶³¾î¶ß¸®°í ±× ¾×À» ÅëÇØ¼­ ÇǺΠǥ¸éÀ» ¹Ù´Ã·Î ±ÜÀ¸¸é À¯¸®µÇ´Â È­ÇÐ Àü´Þ ¹°Áú ¶§¹®¿¡ ÆØÁø ¹× È«¹ÝÀÌ ÃâÇöÇÑ´Ù. ¾Ë·¹¸£±â¿ø °Ë»çÀÎ °æ¿ì´Â ÆØÁø°æ ¶Ç´Â È«¹Ý°æÀÌ ´ëÁ¶ÀÇ 2¹è ÀÌ»ó, ȤÀº ±¸ÁøÀÇ Á÷°æÀÌ 5mm ÀÌ»óÀ» ¾ç¼ºÀ¸·Î ÇÑ´Ù.
  • inflammatory erythema
    ¿°Áõ¼º È«¹Ý
  • Jacquet's erythema
    ÀðÄÉ È«¹Ý
    ±âÀú±Í Àڱؿ¡ ÀÇÇØ À¯¾ÆÀÇ µÐºÎ¿¡ »ý±â´Â È«¹Ý.
  • ninthday erythema
    ±¸ÀÏ È«¹Ý
  • nodular erythema
    °áÀý¼º È«¹ÝÁõ
    ³ÐÀû ´Ù¸®ÀÇ ¹Ù±ùÂÊ, ÆÈÀÇ ÇǺγ» ¶Ç´Â ÇÇÇÏ¿¡ °­³²Äá ¶Ç´Â »õ¾Ë¸¸ÇÑ Å©±âÀÇ ´ãÈ«»ö ȤÀº ¼±È«»öÀÇ °áÀýÀÌ »ý±â´Â ÇǺκ´. ¹ß¿­, °üÀýÅë µîÀÇ Àü±¸ Áõ»óÀÌ ÀÖ´Ù. ·ù¸ÓƼ¼º, °áÇÙ¼ºÀÇ °ÍÀÌ ¸¹´Ù.
  • sharply delimited dedmatous erythema
    ¶Ñ·ÇÇÑ º¯¿¬ÀÇ ÁøÇǼº È«¹Ý
  • spotty erythema
    ¹ÝÁ¡¼º È«¹Ý
  • absorbed dose conversion factor
    Èí¼ö¼±·® º¯È¯ °è¼ö
  • air dose
    °øÁß ¼±·®, °ø±âÁß ¼±·®
    ´Ù¸¥ ¹°Ã¼¿¡ ÀÇÇÑ »ê¶õ¼±À» Á¦¿ÜÇÑ °ø±â ÁßÀÇ ¼±·®. ÀϹÝÀûÀ¸·Î ¹°Ã¼ÀÇ Ç¥¸é¿¡ À־µµ, ¶Ç´Â »ýü Á¶Á÷ ³»ÀÇ ÀÏ Á¡¿¡¼­ÀÇ ¼±·®À¸·Î¼­µµ ¸ðµç »ê¶õ¼±ÀÇ ¿µÇâÀ» ¹Þ±â ¶§¹®¿¡ °øÁß ¼±·®º¸´Ù ¸¹¾ÆÁø´Ù.
  • average dose
    Æò±Õ ¿ë·®, Æò±Õ Á¶»ç·®
  • average maintenance dose
    µð±âÅ»¸®½º Æò±Õ À¯Áö·®
  • basal dose
    ±âº» ¼±·®
  • booster dose
    Ãß°¡ Á¢Á¾·®
  • committed effective dose equivalent
    ¿¹Å¹ À¯È¿ ¼±·® ´ç·®
  • cumulative absorbed dose
    ´©Àû ¼±·®, ´©Àû Èí¼ö¼±·®
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
erythema arthriticum epidemicum <microbiology> An infection by Streptobacillus moniliformis marked by initial chills and high fever (gradually subsiding), by arthritis usually in the larger joints and spine, and by a rash occurring chiefly over the joints and on the extensor surfaces of the extremities.
Haverhill fever is used to indicate Streptobacillus moniliformis infections not associated with rat bite resulting from contaminated food or water.
Synonym: erythema arthriticum epidemicum.
Origin: Haverhill, MA, where an epidemic occurred in 1926
(05 Mar 2000)
erythema bullosum Erythema multiforme with formation of large vesicles or bullae.
(05 Mar 2000)
erythema caloricum A reticulated, pigmented, macular eruption that occurs, mostly on the shins, of bakers, stokers, and others exposed to radiant heat.
Synonym: erythema ab igne, toasted shins.
(05 Mar 2000)
erythema chronicum migrans The classic initial rash of Lyme disease. In the early phase of the illness, within hours to weeks of the tick bite, the local skin develops an expanding ring of unraised redness. There may be an outer ring of brighter redness and a central area of clearing. For more information, see LYME DISEASE.
(12 Dec 1998)
erythema circinatum Erythema multiforme in which the lesions are grouped in more or less circular fashion.
(05 Mar 2000)
erythema dyschromicum perstans Variously sized gray or red, slightly elevated macular lesions that tend to coalesce on the trunk, extremities, and face, commonly in dark-skinned Latin Americans; of unknown cause.
Synonym: ashy dermatosis.
(05 Mar 2000)
erythema elevatum diutinum A chronic symmetrical eruption of flattened nodules, of a pinkish or purplish colour, occurring in plaques on the buttocks and extensors of wrists, elbows, and knees, becoming fibrotic and finally scarring; early lesions show necrotizing vasculitis with fibrinoid or lipid deposits in vessel walls.
Synonym: Bury's disease.
(05 Mar 2000)
erythema exfoliativa Familial continual skin peeling characterised by a separation of stratum corneum in leaflike flakes occurring everywhere except on the palms and soles; the cause is unknown.
Synonym: erythema exfoliativa, erythroderma exfoliativa.
(05 Mar 2000)
erythema figuratum perstans A chronic recurring erythematous eruption consisting of small and large annular lesions, with a scant marginal scale, usually of unknown cause.
Synonym: erythema figuratum perstans.
(05 Mar 2000)
erythema fugax An obsolete term for a diffuse and fleeting erythema from emotional stimuli.
(05 Mar 2000)
erythema gyratum Erythema circinatum in which the various ringed lesions overlap each other.
(05 Mar 2000)
erythema induratum A type of panniculitis characterised histologically by the presence of granulomas, vasculitis, and necrosis. It is traditionally considered to be the tuberculous counterpart of nodular vasculitis, but is now known to occur without tuberculous precedent. It is seen most commonly in adolescent and menopausal women, is initiated or exacerbated by cold weather, and typically presents as one or more recurrent erythrocyanotic nodules or plaques on the calves. The nodules may progress to form indurations, ulcerations, and scars.
(12 Dec 1998)
erythema infectiosum <dermatology> An acute viral infection (human parvovirus) in children that manifests with a fever and a unique facial rash (slapped cheek appearance). After 1-2 days the rash will often spread to the extremities and trunk. The illness is nonserious and self-limiting. Environmental factors such as sunlight, hot baths and emotional factors can cause the rash to recur. Referred to as fifth disease or erythema infectiosum.
(27 Sep 1997)
erythema intertrigo See: intertrigo.
(05 Mar 2000)
erythema iris Concentric rings of erythema varying in intensity, characteristic of erythema multiforme.
Synonym: herpes iris.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á